Helping Patients Find Tazarotene: A Provider's Workflow Guide

Your patient needs Tazarotene, but their pharmacy says it's out of stock. This scenario is playing out in dermatology practices across the country in 2026. As a prescriber, you're in a unique position to help — not just by writing the prescription, but by guiding patients through the availability landscape.

This guide provides a practical, step-by-step workflow for helping patients locate Tazarotene and maintain continuity of care when supply is tight.

Current Tazarotene Availability

The Tazarotene supply picture in 2026 is characterized by inconsistency rather than complete unavailability:

• Generic cream 0.1% — Most commonly prescribed; experiencing the most frequent supply gaps
• Generic gel 0.05% and 0.1% — Generally better availability than cream
• Generic cream 0.05% — Moderate availability; less commonly prescribed for acne (typically used for psoriasis)
• Brand-name Tazorac — Available but decreasingly stocked as pharmacies favor generics
• Fabior foam 0.1% — Sporadic availability; limited pharmacy stocking

For a full analysis of supply factors, see our provider shortage briefing.

Why Patients Can't Find Tazarotene

Understanding the root causes helps you advise patients effectively:

Supply-Side Factors

• Few generic manufacturers — A small number of ANDA holders means any single production disruption creates downstream shortages
• Specialized raw materials — Tazarotene's active pharmaceutical ingredient requires complex synthesis with limited global suppliers
• Low production priority — Compared to high-volume generics, Tazarotene has smaller market demand, giving it lower priority in manufacturer production schedules

Pharmacy-Side Factors

• Algorithmic ordering — Chain pharmacies use demand-based algorithms; low-volume locations may not stock Tazarotene at all
• Wholesaler allocation — During tight supply, wholesalers may allocate limited quantities per pharmacy
• Formulary shifts — As insurance plans prefer generics, some pharmacies have reduced brand-name Tazorac inventory

Payer-Side Factors

• Prior authorization delays — PA requirements slow time-to-fill, creating gaps in treatment
• Step therapy — Plans requiring trial of Adapalene or Tretinoin first delay Tazarotene access
• Cost barriers — Even with PA approval, copays may push patients toward alternatives

What Providers Can Do: 5 Steps

Step 1: Verify Availability Before Prescribing

Before sending a Tazarotene prescription, check availability using Medfinder for Providers. This real-time pharmacy stock tool lets you or your staff identify which pharmacies near your patient currently have Tazarotene in stock. Send the prescription to a pharmacy with confirmed availability to avoid patient frustration and treatment delays.

Step 2: Write Flexible Prescriptions

When clinically appropriate, build flexibility into your prescriptions:

• Add a note: "May substitute cream for gel or gel for cream if prescribed formulation unavailable"
• Consider writing for the strength and formulation most likely to be in stock (gel formulations have been more consistently available)
• If your state allows, write for "Tazarotene 0.1% topical" without specifying vehicle, allowing the pharmacist to dispense what's available

Step 3: Prepare a Backup Plan

For patients starting Tazarotene or those with a history of difficulty filling:

• Discuss alternative retinoids upfront: Tretinoin for acne/photoaging, Calcipotriene for psoriasis
• Consider writing a contingency prescription: "Fill Tretinoin 0.05% cream if Tazarotene unavailable after 5 business days"
• Document the backup plan in the chart so any covering provider can execute it

Step 4: Streamline Prior Authorization

If Tazarotene requires PA through the patient's insurance:

• Document prior treatment trials (Adapalene, Tretinoin) with specific dates, durations, and outcomes
• Clearly state the indication and why Tazarotene is preferred (e.g., psoriasis indication not covered by Adapalene)
• Use diagnosis-specific language that matches payer criteria
• Appeal denials promptly — include peer-reviewed literature supporting Tazarotene for the specific indication

Step 5: Connect Patients with Cost Resources

Cost barriers compound availability issues. Equip your patients with:

• Discount cards: GoodRx, SingleCare, and RxSaver can reduce generic Tazarotene to $40–$80
• Manufacturer programs: Allergan/AbbVie copay cards for brand Tazorac
• Patient assistance: AbbVie Patient Assistance Foundation for uninsured patients
• Direct patients to our Tazarotene savings guide

Therapeutic Alternatives at a Glance

When Tazarotene is unavailable, these alternatives are supported by evidence:

For Acne

• Tretinoin 0.025%–0.1% — Most direct substitute; widely available generic; $15–$60
• Adapalene 0.1% (OTC) or 0.3% (Rx) — Less irritating; 0.1% available without prescription; $12–$80
• Trifarotene 0.005% (Aklief) — Newest option; approved for face and trunk; brand-only ~$400–$600

For Psoriasis

• Calcipotriene 0.005% — Vitamin D analog; first-line topical; $30–$100 generic
• Calcipotriene/betamethasone (Enstilar, Taclonex) — Combination; strong evidence; check formulary
• Topical corticosteroids — Appropriate for flares; match potency to body site

For Photoaging

• Tretinoin 0.025%–0.05% — Gold standard; extensive long-term data; well-tolerated at lower strengths

For patient-facing information, direct them to our alternatives guide.

Workflow Tips for Your Practice

Front Desk / MA Workflow

1. When a patient reports difficulty filling Tazarotene, check Medfinder for nearby pharmacy availability
2. If the medication is found in stock, transfer or send a new prescription to that pharmacy
3. If unavailable, escalate to the prescriber for alternative medication decision

Prescriber Workflow

1. Review the patient's treatment history and indication
2. Determine if formulation switch (cream ↔ gel ↔ foam) is acceptable
3. If Tazarotene is truly unavailable, select the most appropriate alternative and update the treatment plan
4. Document the supply-driven change in the patient's chart

Refill Management

• Encourage patients to refill 7–10 days early
• Set up refill reminders through your patient portal
• For patients with chronic conditions (psoriasis), consider 90-day supply prescriptions through mail-order pharmacy

Patient Education Handouts

Share these resources with affected patients:

• How to find Tazarotene in stock
• Tazarotene shortage update for 2026
• Tazarotene drug interactions
• What is Tazarotene?

Final Thoughts

Tazarotene availability challenges in 2026 require a proactive approach from prescribers. By verifying stock before prescribing, writing flexible prescriptions, preparing backup plans, and connecting patients with cost resources, you can minimize treatment disruptions and maintain patient satisfaction.

Medfinder for Providers is designed to fit into your existing workflow and help your team navigate medication availability in real time. The goal is simple: keep your patients on effective treatment, even when supply chains don't cooperate.